{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:09:14Z","timestamp":1782122954046,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.maturitas.2026.108894","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:04:51Z","timestamp":1771488291000},"page":"108894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Menopausal hormone therapy and breast cancer: Balancing risks and benefits"],"prefix":"10.1016","volume":"208","author":[{"given":"Rishitha","family":"Bollam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisandra","family":"Shufelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.maturitas.2026.108894_bb0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM198101013040104","article-title":"Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer","volume":"304","author":"Ingle","year":"1981","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.maturitas.2026.108894_bb0015","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/cancers15143647","article-title":"Revisiting estrogen for the treatment of endocrine-resistant breast cancer: novel therapeutic approaches","volume":"15","author":"Shete","year":"2023","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.maturitas.2026.108894_bb0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol","volume":"93","author":"Song","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108894_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"Jama"},{"issue":"13","key":"10.1016\/j.maturitas.2026.108894_bb0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.maturitas.2026.108894_bb0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/GME.0b013e31827d38a5","article-title":"Impact of the severity of vasomotor symptoms on health status, resource use, and productivity","volume":"20","author":"Whiteley","year":"2013","journal-title":"Menopause"},{"issue":"22","key":"10.1016\/j.maturitas.2026.108894_bb0040","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials","volume":"285","author":"Torgerson","year":"2001","journal-title":"Jama"},{"issue":"14","key":"10.1016\/j.maturitas.2026.108894_bb0045","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.maturitas.2026.108894_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women\u2019s Health Initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2026.108894_bb0055","author":"Network NCC"},{"key":"10.1016\/j.maturitas.2026.108894_bb0060","author":"Network NCC"},{"issue":"9","key":"10.1016\/j.maturitas.2026.108894_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx001","article-title":"Mammographic density change with estrogen and progestin therapy and breast cancer risk","volume":"109","author":"Byrne","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.maturitas.2026.108894_bb0070","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2016.6326","article-title":"Population-attributable risk proportion of clinical risk factors for breast cancer","volume":"3","author":"Engmann","year":"2017","journal-title":"JAMA Oncol."},{"issue":"24","key":"10.1016\/j.maturitas.2026.108894_bb0075","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.maturitas.2026.108894_bb0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat. Med."},{"issue":"9","key":"10.1016\/j.maturitas.2026.108894_bb0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jacr.2023.04.002","article-title":"Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR","volume":"20","author":"Monticciolo","year":"2023","journal-title":"J. Am. Coll. Radiol."},{"issue":"10","key":"10.1016\/j.maturitas.2026.108894_bb0090","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/GME.0000000000002243","article-title":"Influencing factors on women\u2019s attitudes toward hormone therapy acceptance for menopause treatment: a systematic review","volume":"30","author":"Pershad","year":"2023","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.maturitas.2026.108894_bb0095","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.fertnstert.2004.11.059","article-title":"An update: spontaneous premature ovarian failure is not an early menopause","volume":"83","author":"Nelson","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2026.108894_bb0100","series-title":"Current Concepts in Menopausal Hormone Therapy and Breast Cancer","first-page":"159","author":"Kling","year":"2025"},{"issue":"4","key":"10.1016\/j.maturitas.2026.108894_bb0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/AOG.0000000000003729","article-title":"Clinical effects of early or surgical menopause","volume":"135","author":"Kingsberg","year":"2020","journal-title":"Obstet. Gynecol."},{"issue":"13","key":"10.1016\/j.maturitas.2026.108894_bb0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.maturitas.2026.108894_bb0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women\u2019s Health Initiative randomized trials","volume":"318","author":"Manson","year":"2017","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.maturitas.2026.108894_bb0120","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"20","key":"10.1016\/j.maturitas.2026.108894_bb0125","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/jama.2024.6542","article-title":"The Women\u2019s Health Initiative randomized trials and clinical practice: a review","volume":"331","author":"Manson","year":"2024","journal-title":"Jama"},{"issue":"9382","key":"10.1016\/j.maturitas.2026.108894_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the million women study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.maturitas.2026.108894_bb0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"Jama"},{"issue":"18","key":"10.1016\/j.maturitas.2026.108894_bb0140","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/djq316","article-title":"Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women\u2019s health initiative observational study","volume":"102","author":"Li","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.maturitas.2026.108894_bb0145","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.SLA.0000059969.64262.87","article-title":"Rating the risk factors for breast cancer","volume":"237","author":"Singletary","year":"2003","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.maturitas.2026.108894_bb0150","first-page":"1183","article-title":"World Cancer Research Fund international: continuous update project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk","volume":"30","author":"Chan","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"23","key":"10.1016\/j.maturitas.2026.108894_bb0155","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.maturitas.2026.108894_bb0160","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/ijc.34316","article-title":"Breast density and risk of breast cancer","volume":"152","author":"Lynge","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"13","key":"10.1016\/j.maturitas.2026.108894_bb0165","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-024-07307-9","article-title":"Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis","volume":"206","author":"Chlebowski","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.maturitas.2026.108894_bb0175","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/GME.0000000000001115","article-title":"Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study","volume":"25","author":"Shufelt","year":"2018","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.maturitas.2026.108894_bb0185","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.108894_bb0190","first-page":"undefined","article-title":"Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2","author":"Kotsopoulos","year":"2025","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.maturitas.2026.108894_bb0195","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-137-10-200211190-00008","article-title":"Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer","volume":"137","author":"Chen","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.maturitas.2026.108894_bb0200","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/GME.0000000000002021","article-title":"Estrogen therapy and breast cancer in randomized clinical trials: a narrative review","volume":"29","author":"Pan","year":"2022","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0294-5","article-title":"Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis","volume":"5","author":"Asi","year":"2016","journal-title":"Syst. Rev."},{"issue":"6","key":"10.1016\/j.maturitas.2026.108894_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.maturitas.2026.108894_bb0215","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"issue":"10204","key":"10.1016\/j.maturitas.2026.108894_bb0220","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.maturitas.2026.108894_bb0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2053369120957514","article-title":"The British Menopause Society & Women\u2019s health concern 2020 recommendations on hormone replacement therapy in menopausal women","volume":"26","author":"Hamoda","year":"2020","journal-title":"Post Reprod. Health"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal estrogen therapy use and survival in females with breast cancer","volume":"10","author":"McVicker","year":"2024","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108894_bb0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr3677","article-title":"Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes","volume":"16","author":"Smith","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jwh.2013.4392","article-title":"Evaluation of the efficacy and safety of bazedoxifene\/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the selective estrogens, menopause and response to therapy (SMART) trials","volume":"23","author":"Pinkerton","year":"2014","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"11","key":"10.1016\/j.maturitas.2026.108894_bb0245","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1089\/jwh.2015.5558","article-title":"Pooled analysis of the effects of conjugated estrogens\/Bazedoxifene on vasomotor symptoms in the selective estrogens, menopause, and response to therapy trials","volume":"25","author":"Archer","year":"2016","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"5","key":"10.1016\/j.maturitas.2026.108894_bb0250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2022.24140","article-title":"Management of menopausal symptoms: a review","volume":"329","author":"Crandall","year":"2023","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108894_bb0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2013.06.008","article-title":"Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study","volume":"76","author":"Palacios","year":"2013","journal-title":"Maturitas"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222600071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222600071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T21:24:53Z","timestamp":1779485093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851222600071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"alternative-id":["S037851222600071X"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.108894","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopausal hormone therapy and breast cancer: Balancing risks and benefits","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.108894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108894"}}